Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PTL Gains Compliance for Nanoparticle Tracking Analysis | Contract Pharma

What are you searching for?

Sign in
Breaking News

PTL Gains Compliance for Nanoparticle Tracking Analysis

Expands capabilities to regulated clients

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Particle Technology Labs (PTL) has established cGMP compliance for Nanoparticle Tracking Analysis (NTA), which is now available on a contract basis to the pharma industry. NTA has been adopted for both research-based projects and as a quality control tool for regulated industries. PTL’s NanoSight LM10-HSB instrument is certified cGMP as of June 4, 2013, and expands the company’s analytical capabilities by allowing quantification of particle concentrations in the submicron range.
 
William Kopesky, PTL’s director of Analytical Services, said, “We are excited to have this new technology in our lab. As a cGMP qualified instrument, the NanoSight LM10-HSB expands our capabilities to our regulated clients, providing them with an accurate particle concentration and size device in the submicron range.”
 
Mr. Kopesky added, “NTA has significantly better resolution than DLS, as we have verified here at PTL. Its ability to count particles in the submicron range constitutes a paradigm shift. Access to NTA technology is a benefit for several applications. Thanks to the sensitivity of NTA technology, PTL can now detect an even lower level of submicron particles.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics